Intelligent Bio Solutions Inc. (INBS) Investor Relations Documents

Intelligent Bio Solutions Inc. (INBS) investor relations documents from the company's IR site: 19 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-19Press releaseIntelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed
2026-08-11Press releaseIntelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screen
2026-08-05Press releaseIntelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
2026-08-03Press releaseIntelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Finger
2026-07-23Press releaseIntelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. M
2026-07-21Press releaseIntelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entr
2026-06-16Press releaseIntelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry
2026-06-02Press releaseIntelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission
2026-05-13Press releaseIntelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
2026-04-20Press releaseIntelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
2026-04-17Press releaseIntelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Ma
2026-04-02Press releaseIntelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion
2026-03-26Press releaseIntelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant
2026-02-25Press releaseIntelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Dri
2026-02-24Press releaseIntelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Con
2026-02-05Press releaseIntelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Yea
2026-01-28Press releaseIntelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into
2026-01-02Press releaseIntelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Press releaseFiscal First Quarter 2026 Press Release

INBS overview · INBS earnings · INBS financials · INBS KPIs · INBS ownership · INBS peers · INBS filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.